ArticleTobacco induced diseases2026
Impact of cigarette toxicants on sarcopenic obesity: An in silico network toxicology and molecular dynamics study.
Article in Tobacco induced diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSarcopenic obesity (SO) is a geriatric metabolic syndrome characterized by muscle mass loss, muscle strength decline, and excessive fat accumulation. Nicotine and coal tar disrupt skeletal muscle homeostasis and lipid metabolism. This study aims to elucidate the relevant molecular mechanisms by which nicotine and coal tar trigger sarcopenic obesity using an integrated in silico approach.
methodsThis in silico study was conducted in May 2026 using publicly available databases and computational platforms. Targets for nicotine, coal tar, and SO were retrieved from GeneCards and OMIM, and the intersection of targets was identified using Venny. KEGG enrichment was performed to detect key pathways. A protein-protein interaction (PPI) network was constructed via STRING, and the top 10 core genes were ranked by the Maximal Clique Centrality (MCC) algorithm in Cytoscape. Three GEO transcriptomic datasets (GSE290570, GSE262419, GSE226045) were used to cross-validate differentially expressed genes related to nicotine, coal tar, and SO. Molecular docking between nicotine and five core proteins was performed using CB-DOCK2, and 50 ns molecular dynamics simulations with GROMACS were used to assess complex stability via root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), radius of gyration (Rg), solvent-accessible surface area (SASA), and hydrogen-bond analysis.
resultsTwenty intersection targets were identified. Enriched pathways included MAPK, PI3K/Akt, p53, cholesterol metabolism, and ferroptosis. Five core genes (IL1β, IGF1, FGF2, CTNNB1, and CXCL12) were cross-validated by GEO transcriptomic data. Nicotine bound stably to CTNNB1, CXCL12, IGF1, and IL1β with binding energies ranging from -3.3 to -4.2 kcal/mol, whereas FGF2 showed a positive value (0.7). MD simulations confirmed that all complexes maintained structural stability throughout the 50 ns trajectory.
conclusionsNicotine and coal tar may regulate core genes and inflammation- and metabolism-related pathways to promote SO progression. This study provides theoretical references for preventing tobacco exposure-induced SO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.